HEATHER GARROT: Open Payments
NPI 1972289031 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,271 in 123 payments from 23 companies in 2025. Trend: 2023 $205 · 2024 $801 · 2025 $2,271
Food & beverage: $2,271
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 23 | $406 |
| AstraZeneca Pharmaceuticals LP | 7 | $260 |
| Novo Nordisk Inc | 16 | $259 |
| GlaxoSmithKline, LLC. | 10 | $199 |
| PFIZER INC. | 10 | $190 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $164 |
| Sumitomo Pharma America, Inc. | 12 | $157 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $146 |
| Dexcom, Inc. | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 4 | $69 |
Products named: JARDIANCE, AIRSUPRA, GEMTESA, Kerendia, TRELEGY ELLIPTA, MOUNJARO, ELIQUIS, REXULTI.
Industry payments across LA — which companies pay providers there.
